Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
for
Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer,
Location: Cincinnati OH
Sponsor: Jordan Kharofa
Sex: All
Age: 18+
Code: NCT07225036
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Cincinnati OH, Grand Rapids MI, Evanston IL,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase3, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Cincinnati OH, Columbus OH, Detroit MI, Chicago IL,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase3, Recruiting
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial
for
Metastatic Bone Disease
Location: Cincinnati OH, Fort Wayne IN, Aurora CO, Portland OR
Sponsor: Michelle Ghert, MD
Sex: All
Age: 18+
Code: NCT06863129
Recruiting
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
for
Mastectomy; Lymphedema, Breast Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT06574022
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Cincinnati OH, Cleveland OH, Detroit MI, Durham NC,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT06859762
Phase1, Recruiting
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
for
Head and Neck Cancer,
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT07213934
Phase1, Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Cincinnati OH, North Canton OH, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951711
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Location: Cincinnati OH, Columbus OH, Charlottesville VA,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Location: Cincinnati OH, Ann Arbor MI, Pittsburgh PA, Chicago IL,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05878717
Phase2, Phase3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer